explore -WSS

explore

author：hotspot 2025-09-30 06:09:10 - browse：99889

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： In science, is the line between industry and academia shifting?

hotspot

WSS

When prostate cancer spreads, where it goes matters

How a symptom of dementia informs our understanding of creativity

Venture capitalist Bob Kocher on the state of digital health

Winners, losers from Medicare’s list of drugs subject to price talks

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Diversity in medical illustrations gets boost from Chidiebere Ibe

hotspot

explore

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why more medical students aren't specializing in primary care

Medical leaders decry Supreme Court decision on affirmative action

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Malaria cases in Florida and Texas: Here’s what you need to know

Diversity in medical illustrations gets boost from Chidiebere Ibe

Medical records are filled with copy

What AAP's gender

Duchenne breakthrough therapy leaves behind pioneering families

What AAP's gender

leisure time

How Long Island became the ‘eugenics capital of the world’

Wearables generate powerful data but its not useful to doctors, yet

Criminal prosecution for violating HIPAA: an emerging threat

In science, is the line between industry and academia shifting?

How a symptom of dementia informs our understanding of creativity

Australia’s approach to dialysis celebrates life

hotspot

focus

hotspot

focus